290 related articles for article (PubMed ID: 18184473)
21. [Significance of tumor markers in the treatment of patients with ovarian malignancies].
Tomoda Y; Kano T; Furuhashi Y; Mizuno K; Kamiya N; Mizuno K; Sakakibara K; Ohta M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3027-33. PubMed ID: 2445293
[TBL] [Abstract][Full Text] [Related]
22. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
23. [Comparative evaluation of diagnostic significance of carbohydrate antigen CA125 and cancer-embryonal antigen in ovarian cancer].
Lapchenkov VI; Dudarev AL; Vinokurov VL; Iurkova LE; Barbanel EIu
Vestn Rentgenol Radiol; 1993; (5):30-1. PubMed ID: 7801580
[TBL] [Abstract][Full Text] [Related]
24. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
[TBL] [Abstract][Full Text] [Related]
25. [The determination of medical reference values for tumor markers in cerebrospinal fluid].
Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Cao XT
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):355-6. PubMed ID: 19563718
[TBL] [Abstract][Full Text] [Related]
26. Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer.
Camlica H; Duranyildiz D; Tas F; Yasasever V
Am J Clin Oncol; 2008 Dec; 31(6):585-8. PubMed ID: 19060592
[TBL] [Abstract][Full Text] [Related]
27. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
[TBL] [Abstract][Full Text] [Related]
29. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
Jiang XT; Tao HQ; Zou SC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
[TBL] [Abstract][Full Text] [Related]
30. Ovarian vein vs peripheral blood CA125 serum levels: a comparative study.
Podnos YD; Gamboa G; Kurosaki T; Buller R; Walker JL; Manetta A
Gynecol Oncol; 1997 Jul; 66(1):71-4. PubMed ID: 9234924
[TBL] [Abstract][Full Text] [Related]
31. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer.
Nakae M; Iwamoto I; Fujino T; Maehata Y; Togami S; Yoshinaga M; Douchi T
J Obstet Gynaecol Res; 2006 Jun; 32(3):309-14. PubMed ID: 16764622
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic value of determination of CEA, CA125, CA153 and CA199 assay in pleural fluid for lung cancer].
Wu G; Ba J; Wang E; Teng Y; Fan X
Zhongguo Fei Ai Za Zhi; 2004 Feb; 7(1):35-7. PubMed ID: 21211189
[TBL] [Abstract][Full Text] [Related]
33. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer.
Sliutz G; Tempfer C; Kainz C; Mustafa G; Gitsch G; Koelbl H; Biegelmayer C
Anticancer Res; 1995; 15(3):1127-9. PubMed ID: 7645936
[TBL] [Abstract][Full Text] [Related]
34. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
Wang XF; Wu YH; Wang MS; Wang YS
Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
[TBL] [Abstract][Full Text] [Related]
36. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
37. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
Eskelinen M; Kataja V; Hämäläinen E; Kosma VM; Penttilä I; Alhava E
Anticancer Res; 1997; 17(2B):1231-4. PubMed ID: 9137478
[TBL] [Abstract][Full Text] [Related]
38. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
39. Detection of ovarian cancer by determination of CA 125 in different patohistologycal types of tumor according to age.
Vranes HS; Klarić P; Kuna K; Kraljević Z; Gall V; Jukić M
Coll Antropol; 2012 Jun; 36(2):425-9. PubMed ID: 22856226
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary.
Kikkawa F; Nawa A; Tamakoshi K; Ishikawa H; Kuzuya K; Suganuma N; Hattori S; Furui K; Kawai M; Arii Y
Cancer; 1998 Jun; 82(11):2249-55. PubMed ID: 9610706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
